WEP Clinical provides end to end solutions to help get needed medicines to patients and hospitals across the globe. From our pre-approval Expanded Access Programsand post-approval Named Patient Programs, to our clinical trial sourcing services and warehouse capabilities, WEP Clinical offers a robust service to customers. With nearly 10 years of experience and a global reach, we are passionate about helping those in need.
WEP Clinical helps patients and physicians obtain early access to medicines that are currently unavailable in their country. These can be investigational (Pre-Approval) drugs that are still in clinical trials, or commercialized (Post-Approval) drugs that are not yet available in all countries. We provide a vital service that helps patients access treatments for rare diseases, cancer, and other life-threatening or debilitating conditions.
WEP Clinical sets up and manages Expanded Access Programs for Pre-Approval drugs, and Named Patient Programs for Post-Approval drugs on behalf of pharmaceutical companies. We provide end-to-end solutions including Patient & Physician Qualification, Global Regulatory Management, Real World Data Collection, Warehousing, Distribution, and Product Commercialization Services. .